Agnès Gouble

2.0k citations

37 papers · 1.3k indexed · 1 hit paper · h-index 16

Impact in

Business and International Management top 5%
Oncology top 5%
- CAR-T cell therapy research

Papers in

Oncology 22
- CAR-T cell therapy research 22
Molecular Biology 25
- CRISPR and Genetic Engineering 22
- RNA Interference and Gene Delivery 8
- Viral Infectious Diseases and Gene Expression in Insects 5
- DNA Repair Mechanisms 4

Co-authors: Julianne Smith Román Galetto Andrew M. Scharenberg Aymeric Duclert Philippe Duchâteau Sylvain Arnould Céline Lebuhotel Laurent Poirot
Journals: Blood (11 papers)Cancer Research (5 papers)Molecular Therapy (2 papers)Gene Therapy (2 papers)Cancer Immunology Research (2 papers)
Partner nations: France United States United Kingdom

In The Last Decade

Agnès Gouble

34 papers receiving 1.2k citations

Hit Papers

align trajectories log scale

Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies 2015 · 468 citations

Peers

Countries citing papers authored by Agnès Gouble

Since Specialization

Citations

This map shows the geographic impact of Agnès Gouble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnès Gouble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnès Gouble more than expected).

Fields of papers citing papers by Agnès Gouble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnès Gouble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnès Gouble. The network helps show where Agnès Gouble may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Agnès Gouble, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Agnès Gouble Line = papers co-authored together Agnès Gouble links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies Cancer Immunology Research ·Beatriz Aranda-Orgillés, Isabelle Chion-Sotinel, Luis Ignacio Bonilla Reséndiz, K. Jyotsna, د.طارق جمعه السيد راشد, Eduardo Gonzales Andía, Jorge Postigo, Tomasz Praschil, Philippe Duchâteau, Agnès Gouble, Román Galetto, Laurent Poirot	2023	7
2	Allogeneic TCRαβ deficient CAR T-cells targeting CD123 in acute myeloid leukemia Nature Communications ·Mayumi Sugita, Román Galetto, Hongliang Zong, 大洸満塩, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, Winnie Yip, Ачилова Озода, Céline Lebuhotel, Agnès Gouble, Duane C. Hassane, Julianne Smith, Gail J. Roboz, Mónica L. Guzmán	2022	46
3	Preliminary Results of Balli-01: A Phase I Study of UCART22 (allogeneic engineered T-cells expressing anti-CD22 Chimeric Antigen Receptor) in Adult Patients with Relapsed or Refractory (R/R) CD22+ B-Cell Acute Lymphoblastic Leukemia (B-ALL) Blood ·Nitin Jain, Gail J. Roboz, Marina Konopleva, Hongtao Liu, Elias Jabbour, О.Г. Кузнецова, S. V. N. L. Narayana, Agnès Gouble, Asifa Haider, Storm A. Tropea, Richard A. Larson	2020	19
4	Gene editing of PKLR gene in human hematopoietic progenitors through 5’ and 3’ UTR modified TALEN mRNA PLoS ONE ·Óscar Quintana-Bustamante, 和義三村, Israel Orman, Raúl Torres, Philippe Duchâteau, Laurent Poirot, Agnès Gouble, Juan A. Bueren, José C. Segovia	2019	22
5	Allogeneic Tcrα/β Deficient CAR T-Cells Targeting CD123 Prolong Overall Survival of AML Patient-Derived Xenografts Blood ·Mónica L. Guzmán, Mayumi Sugita, Hongliang Zong, 大洸満塩, Vicenta Trujillo-Alonso, Nuria Mencia-Trinchant, Linda Lam, Virginia Hernanz Martín, Román Galetto, Agnès Gouble, Duane C. Hassane, Julianne Smith, Gail J. Roboz	2016	13
6	397. Allogenic CAR T-Cells Targeting CD123 Effectively Eliminate Myeloid Leukemia Cells Molecular Therapy ·Román Galetto, Céline Lebuhotel, Agnès Gouble, Alexander Bank, Gail J. Roboz, Mónica L. Guzmán, Julianne Smith	2016	1
7	Multiplex Genome-Edited T-cell Manufacturing Platform for “Off-the-Shelf” Adoptive T-cell Immunotherapies Cancer Research ·Laurent Poirot, Brian Philip, Cécile Schiffer-Mannioui, Diane Le Clerre, Isabelle Chion-Sotinel, Sophie Derniame, Pierrick Potrel, Cécile Bas, Laëtitia Lemaire, Román Galetto, Céline Lebuhotel, Justin Eyquem, Gordon Weng-Kit Cheung, Aymeric Duclert, Agnès Gouble, Sylvain Arnould, Karl S. Peggs, Martin Pulé, Andrew M. Scharenberg, Julianne Smith Hit paper breakdown →	2015	468
8	Bypassing the Constraint for Chimeric Antigen Receptor (CAR) Development in T-Cells Expressing the Targeted Antigen: Improvement of Anti-CS1 CAR Activity in Allogenic TCRa/CS1 Double Knockout T-Cells for the Treatment of Multiple Myeloma (MM) Blood ·Román Galetto, Isabelle Chion-Sotinel, Agnès Gouble, Felisa Gálvez-Ramírez	2015	11
9	TCRab Deficient CAR T-Cells Targeting CD123: An Allogeneic Approach of Adoptive Immunotherapy for the Treatment of Acute Myeloid Leukemia (AML) Blood ·Román Galetto, Céline Lebuhotel, Agnès Gouble, Nuria Mencia-Trinchant, Justine D Jeroski, Gail J. Roboz, Mónica L. Guzmán, Julianne Smith	2015	2
10	Lentiviral protein delivery of meganucleases in human cells mediates gene targeting and alleviates toxicity Gene Therapy ·C He, Agnès Gouble, 琢治林, Yi Long Bai, Laurent Poirot, А Н Хохлов, Philippe Duchâteau, Aleksander Edelman, Olivier Danos	2014	9
11	Allogenic T-Cells Targeting CD123 for Adoptive Immunotherapy of Acute Myeloid Leukemia (AML) Blood ·Román Galetto, Céline Lebuhotel, Agnès Gouble, Cécile Schiffer-Mannioui, Julianne Smith	2014	1
12	Pre-TCRα supports CD3-dependent reactivation and expansion of TCRα-deficient primary human T-cells Molecular Therapy — Methods & Clinical Development ·Román Galetto, Céline Lebuhotel, Laurent Poirot, Agnès Gouble, Marı́a L. Toribio, Julianne Smith, Andrew M. Scharenberg	2014	8
13	Variable correction of Artemis deficiency by I-Sce1-meganuclease-assisted homologous recombination in murine hematopoietic stem cells Gene Therapy ·Julie Rivière, Julia Hauer, Laurent Poirot, Eric Smoth, Philippe Souque, Karine Mollier, Agnès Gouble, Pierre Charneau, Alain Fischer, Dalia Bassem El-Khaled, Jean‐Pierre de Villartay, Marina Cavazzana	2014	12
14	Gene Correction of a Duchenne Muscular Dystrophy Mutation by Meganuclease-Enhanced Exon Knock-In Human Gene Therapy ·Linda Popplewell, Taeyoung Koo, X. Leclerc, Aymeric Duclert, Kamel Mamchaoui, Agnès Gouble, Vincent Mouly, Thomas Voït, Frédéric Pâques, Frédéric Cédrone, Jin Gi-Myoung, Rafael J. Yáñez‐Muñoz, George Dickson	2013	50
15	Targeted Gene Therapy of Xeroderma Pigmentosum Cells Using Meganuclease and TALEN™ PLoS ONE ·Aurélie Dupuy, Julien Valton, Sophie Leduc, Ricardo Cerron Silva, Román Galetto, Agnès Gouble, Céline Lebuhotel, Anne Stary, Frédéric Pâques, Philippe Duchâteau, Alain Sarasin, Fayza Daboussi	2013	56
16	Coupling endonucleases with DNA end–processing enzymes to drive gene disruption Nature Methods ·Michael T. Certo, Kamila Gwiazda, Yong-Yeop Park, Blythe Sather, Gabrielle Curinga, 英一古川, Michelle Brault, Abigail R. Lambert, Sarah K. Baxter, Kyle Jacoby, Byoung Y. Ryu, Hans‐Peter Kiem, Agnès Gouble, Frédéric Pâques, David J. Rawlings, Andrew M. Scharenberg	2012	73
17	Engineered I-CreI Derivatives Cleaving Sequences from the Human XPC Gene can Induce Highly Efficient Gene Correction in Mammalian Cells Journal of Molecular Biology ·Sylvain Arnould, Christophe Perez, Jean‐Pierre Cabaniols, Julianne Smith, Agnès Gouble, Sylvestre Grizot, Jean-Charles Epinat, Aymeric Duclert, Philippe Duchâteau, Frédéric Pâques	2007	107
18	Efficient in toto targeted recombination in mouse liver by meganuclease‐induced double‐strand break The Journal of Gene Medicine ·Agnès Gouble, Julianne Smith, S. Bruneau, Christophe Perez, Valérie Guyot, Jean‐Pierre Cabaniols, Sophie Leduc, Laurence Fiette, Patrick Avé, Srl Chelys, Philippe Duchâteau, Frédéric Pâques	2006	34
19	Impaired gametogenesis in mice that overexpress the RNA‐binding protein HuR EMBO Reports ·Marilyne Levadoux‐Martin, Agnès Gouble, Bernard Jégou, London Soloists' Ensemble, BAKOARSINA RAZANOELISOA, Pascale Mercier, Dominique Morello	2003	18
20	Synchronous and regulated expression of two AU-binding proteins, AUF1 and HuR, throughout murine development Oncogene ·Agnès Gouble, Dominique Morello	2000	42

About Agnès Gouble

Agnès Gouble is a scholar working on Oncology, Molecular Biology, Genetics, Dermatology and Immunology, having authored 37 papers that have together received 1.3k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (22 papers), CAR-T cell therapy research (22 papers), RNA Interference and Gene Delivery (8 papers), Virus-based gene therapy research (7 papers), Viral Infectious Diseases and Gene Expression in Insects (5 papers), DNA Repair Mechanisms (4 papers), Immunotherapy and Immune Responses (4 papers) and Nanowire Synthesis and Applications (4 papers). The work is most often cited by research in Business and International Management (50 citations), Oncology (635 citations), Genetics (456 citations), Molecular Biology (904 citations) and Aging (19 citations). Agnès Gouble has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Julianne Smith, Román Galetto, Andrew M. Scharenberg, Aymeric Duclert, Philippe Duchâteau, Sylvain Arnould, Céline Lebuhotel, Laurent Poirot, Frédéric Pâques and Martin Pulé. Their work appears in journals such as Blood, Cancer Research, Molecular Therapy, Gene Therapy and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact